To the full analysis
Neogen stock: growth
NEOGNeogen reported $870.4M in revenue for fiscal 2026, down 2.7% on the prior year, up 13.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
12.9%
per year from 2007 to 2026, per share 7.3%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
9.7%
per year from 2007 to 2026, per share 4.3%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 13.2% | 10.5% | 12.9% |
| Revenue per share | −1.9% | 2.2% | 7.3% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | −10.1% | 4.2% | 9.7% |
| Free cash flow per share | −22.1% | −3.6% | 4.3% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $86.14M | $9.13M | $5.45M |
| 2008 | $102.42M | $12.1M | $5.4M |
| 2009 | $118.72M | $13.87M | $8.15M |
| 2010 | $140.51M | $17.52M | $22.56M |
| 2011 | $172.68M | $22.84M | $21.05M |
| 2012 | $184.05M | $22.51M | $9.86M |
| 2013 | $207.53M | $27.19M | $17.66M |
| 2014 | $247.41M | $28.16M | $10.13M |
| 2015 | $283.07M | $33.53M | $34.17M |
| 2016 | $321.28M | $36.56M | $21.11M |
| 2017 | $358.28M | $43.79M | $45.7M |
| 2018 | $397.93M | $63.15M | $48.19M |
| 2019 | $414.19M | $60.18M | $49.18M |
| 2020 | $418.17M | $59.48M | $61.83M |
| 2021 | $468.46M | $60.88M | $54.38M |
| 2022 | $527.16M | $48.31M | $43.61M |
| 2023 | $822.45M | −$22.87M | −$24.73M |
| 2024 | $924.22M | −$9.42M | −$76.16M |
| 2025 | $894.66M | −$1.09B | −$46.35M |
| 2026 | $870.4M | −$7.9M | $31.9M |
Revenue by segment
How Neogen Corporation makes its money and how that has shifted. Names are as the company reports them.
- Product88%
- Service12%
Figures as a table
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Product | $335.55M | $339.44M | $335.54M | $376.3M | $424.66M | $715.08M | $821.82M | $797.32M | $768.2M | 88.3% |
| Service | $66.7M | $74.75M | $82.63M | $92.16M | $102.5M | $107.37M | $102.4M | $97.35M | $102.2M | 11.7% |
| Total revenue | $397.93M | $414.19M | $418.17M | $468.46M | $527.16M | $822.45M | $924.22M | $894.66M | $870.4M | 100% |
Revenue by region
Where Neogen Corporation generates its revenue.
- Outside the US51%
- United States49%
Figures as a table
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Outside the US | $165.88M | $164.71M | $183.2M | $209.34M | $398.44M | $458.98M | $448.73M | $445.3M | 51.2% |
| United States | $248.3M | $253.46M | $285.26M | $317.82M | $424.01M | $465.24M | $445.94M | $425.1M | 48.8% |
| Total revenue | $414.19M | $418.17M | $468.46M | $527.16M | $822.45M | $924.22M | $894.66M | $870.4M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 May 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Aug 2023)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.